 | Up a level |
Schmid, Sabine; Zhan, Luna; Garcia, Miguel; Dietrich, Kristen; Khan, Khaleeq; Chowdhury, Maisha; Herman, Michael; Patel, Devalben; Zaeimi, Fatemeh; Leighl, Natasha B; Sacher, Adrian; Feld, Ronald; Shepherd, Frances A; Donahoe, Laura; de Perrot, Marc; Cho, B C John; Liu, Geoffrey; Bradbury, Penelope A (2024). Immediate Versus Deferred Systemic Therapy in Patients With Mesothelioma. (In Press). Clinical lung cancer Elsevier 10.1016/j.cllc.2024.04.011
Fares, Aline F; Li, Yao; Jiang, Mei; Brown, M Catherine; Lam, Andrew C L; Aggarwal, Reenika; Schmid, Sabine; Leighl, Natasha B; Shepherd, Frances A; Wang, Zhichao; Diao, Nancy; Wenzlaff, Angela S; Xie, Juntao; Kohno, Takashi; Caporaso, Neil E; Harris, Curtis; Ma, Hongxia; Barnett, Matthew J; Leal, Leticia Ferro; Fernandez-Tardon, G; ... (2023). Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. The lancet. Public health, 8(9), e691-e700. Elsevier 10.1016/S2468-2667(23)00131-7
García-Pardo, Miguel; Czarnecka-Kujawa, Kasia; Law, Jennifer H; Salvarrey, Alexandra M; Fernandes, Roxanne; Fan, Zhen J; Waddell, Thomas K; Yasufuku, Kazuhiro; Liu, Geoffrey; Donahoe, Laura L; Pierre, Andrew; Le, Lisa W; Gunasegaran, Tharsiga; Ghumman, Noor; Shepherd, Frances A; Bradbury, Penelope A; Sacher, Adrian G; Schmid, Sabine; Corke, Lucy; Feng, Jamie; ... (2023). Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial. JAMA Network Open, 6(7), e2325332. American Medical Association 10.1001/jamanetworkopen.2023.25332
Schmid, Sabine; Cheng, Sierra; Chotai, Simren; Garcia, Miguel; Zhan, Luna; Hueniken, Katrina; Balaratnam, Karmugi; Khan, Khaleeq; Patel, Devalben; Grant, Benjamin; Raptis, Roula; Brown, M Catherine; Xu, Wei; Moriarty, Patrick; Shepherd, Frances A; Sacher, Adrian G; Leighl, Natasha B; Bradbury, Penelope A; Liu, Geoffrey (2023). Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer. Clinical lung cancer, 24(1), pp. 40-50. Elsevier 10.1016/j.cllc.2022.09.007
